Gene-environment interactions in the aetiology of systemic lupus erythematosus

Autoimmunity

Volumn 40, Issue 8, 2007, Pages 613-617

  Jönsen, Andreas ^a   Bengtsson, Anders ^a   Nived, Ola ^a   Truedsson, Lennart ^a   Sturfelt, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Environment; Epigenetics; Etiology; Genetics; SLE

Indexed keywords

ACYLTRANSFERASE; ALPHA INTERFERON; GLUTATHIONE TRANSFERASE;

ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNITY; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE INTERACTION; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MUTATION; PATHOGENESIS; RISK; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARYLAMINE N-ACETYLTRANSFERASE; AUTOANTIBODIES; ENVIRONMENT; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OCCUPATIONAL EXPOSURE; PHENOTYPE; SUNLIGHT;

EID: 37449019207     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701511051     Document Type: Article

References (46)

1. Fries, JF and Holman, HR (1975) Systemic lupus erythematosus: A clinical analysis. Major Probl Intern Med, 6, p. v-199.
2. Tan, EM, Cohen, AS, Fries, JF, Masi, AT, McShane, DJ and Rothfield, NF (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25:11, pp. 1271-1277.
3. Pascual, V., Banchereau, J. and Palucka, AK (2003) The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol, 15:5, pp. 548-556.
4. Wandstrat, A. and Wakeland, E. (2001) The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol, 2:9, pp. 802-809.
5. Manderson, AP, Botto, M. and Walport, MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol, 22, pp. 431-456.
6. Edwards, CJ and Cooper, C. (2006) Early environmental exposure and the development of lupus. Lupus, 15:11, pp. 814-819.
7. Arbuckle, MR, McClain, MT, Rubertone, MV, Scofield, RH, Dennis, GJ and James, JA (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 349:16, pp. 1526-1533.
8. Edwards, CJ, Syddall, H., Goswami, R., Goswami, P., Dennison, EM and Cooper, C. (2006) Infections in infancy and the presence of antinuclear antibodies in adult life. Lupus, 15:4, pp. 213-217.
9. Phillips, DI (2006) External influences on the fetus and their long-term consequences. Lupus, 15:11, pp. 794-800.
10. Klareskog, L., Stolt, P., Lundberg, K., Kallberg, H., Bengtsson, C. and Grunewald, J. (2006) A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum, 54:1, pp. 38-46.
11. Tsao, BP (2003) The genetics of human systemic lupus erythematosus. Trends Immunol, 24:11, pp. 595-602.
12. Deapen, D., Escalante, A., Weinrib, L., Horwitz, D., Bachman, B. and Roy-Burman, P. (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum, 35:3, pp. 311-318.
13. Truedsson, L., Sturfelt, G., Johansen, P., Nived, O. and Thuresson, B. (1995) Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: Disease association with the extended haplotype [HLA-B8,SC01, DR17]. J Rheumatol, 22:10, pp. 1852-1861.
14. Nimmerjahn, F. and Ravetch, JV (2006) Fcgamma receptors: Old friends and new family members. Immunity, 24:1, pp. 19-28.
15. Davies, KA, Peters, AM, Beynon, HL and Walport, MJ (1992) Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest, 90:5, pp. 2075-2083.
16. Russell, AI, Graham, DS Cunninghame, Shepherd, C., Roberton, CA, Whittaker, J. and Meeks, J. (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet, 13:1, pp. 137-147.
17. Garred, P., Voss, A., Madsen, HO and Junker, P. (2001) Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun, 2:8, pp. 442-450.
18. Prokunina, L., Castillejo-Lopez, C., Oberg, F., Gunnarsson, I., Berg, L. and Magnusson, V. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet, 32:4, pp. 666-669.
19. Witkin, SS, Gerber, S. and Ledger, WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis, 34:2, pp. 204-209.
20. Tucci, M., Barnes, EV, Sobel, ES, Croker, BP, Segal, MS and Reeves, WH (2004) Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum, 50:6, pp. 1842-1849.
21. Sigurdsson, S., Nordmark, G., Goring, HH, Lindroos, K., Wiman, AC and Sturfelt, G. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet, 76:3, pp. 528-537.
22. Clynes, R., Dumitru, C. and Ravetch, JV (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science, 279:5353, pp. 1052-1054.
23. Matsumoto, K., Watanabe, N., Akikusa, B., Kurasawa, K., Matsumura, R. and Saito, Y. (2003) Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum, 48:2, pp. 486-494.
24. Nguyen, C., Limaye, N. and Wakeland, EK (2002) Susceptibility genes in the pathogenesis of murine lupus. Arthritis Res, 4:3, pp. S255-S263.
25. Sarzi-Puttini, P., Atzeni, F., Iaccarino, L. and Doria, A. (2005) Environment and systemic lupus erythematosus: An overview. Autoimmunity, 38:7, pp. 465-472.
26. Bengtsson, AA, Rylander, L., Hagmar, L., Nived, O. and Sturfelt, G. (2002) Risk factors for developing systemic lupus erythematosus: A case-control study in southern Sweden. Rheumatology (Oxford), 41:5, pp. 563-571.
27. McClain, MT, Heinlen, LD, Dennis, GJ, Roebuck, J., Harley, JB and James, JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med, 11:1, pp. 85-89.
28. Van, GM, Moens, U., Bendiksen, S. and Rekvig, OP (2003) Autoimmunity to nucleosomes related to viral infection: A focus on hapten-carrier complex formation. J Autoimmun, 20:2, pp. 171-182.
29. Harley, JB, Harley, IT, Guthridge, JM and James, JA (2006) The curiously suspicious: A role for Epstein-Barr virus in lupus. Lupus, 15:11, pp. 768-777.
30. Sarzi-Puttini, P., Atzeni, F., Capsoni, F., Lubrano, E. and Doria, A. (2005) Drug-induced lupus erythematosus. Autoimmunity, 38:7, pp. 507-518.
31. Perry Jr., HM, Tan, EM, Carmody, S. and Sakamoto, A. (1970) Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med, 76:1, pp. 114-125.
32. Costenbader, KH and Karlson, EW (2005) Cigarette smoking and systemic lupus erythematosus: A smoking gun?. Autoimmunity, 38:7, pp. 541-547.
33. Rubin, RL, Hermanson, TM, Bedrick, EJ, McDonald, JD, Burchiel, SW and Reed, MD (2005) Effect of cigarette smoke on autoimmunity in murine and human systemic lupus erythematosus. Toxicol Sci, 87:1, pp. 86-96.
34. Lockshin, MD (2006) Sex differences in autoimmune disease. Lupus, 15:11, pp. 753-756.
35. Bijl, M. and Kallenberg, CG (2006) Ultraviolet light and cutaneous lupus. Lupus, 15:11, pp. 724-727.
36. Hess, EV (2002) Environmental chemicals and autoimmune disease: Cause and effect. Toxicol, 181182, pp. 65-70.
37. Fraser, PA, Ding, WZ, Mohseni, M., Treadwell, EL and Dooley, MA (2003) Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: A possible gene-environment interaction for autoimmunity. J Rheumatol, 30:2, pp. 276-282.
38. Suwannaroj, S., Lagoo, A., Keisler, D. and McMurray, RW (2001) Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE). Lupus, 10:4, pp. 258-265.
39. Karlson, EW, Watts, J., Signorovitch, J., Bonetti, M., Wright, E. and Cooper, GS (2007) Effect of glutathione S-TRANSFERASE polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: Results from the roxbury lupus project. Arthritis Rheum, 56:1, pp. 244-254.
40. Cooper, GS, Treadwell, EL, Dooley, MA, Clair, EW St., Gilkeson, GS and Taylor, JA (2004) N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus. J Rheumatol, 31:1, pp. 76-80.
41. Reidenberg, MM, Drayer, DE, Lorenzo, B., Strom, BL, West, SL and Snyder, ES (1993) Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum, 36:7, pp. 971-973.
42. Foppa, I. and Spiegelman, D. (1997) Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable. Am J Epidemiol, 146:7, pp. 596-604.
43. Khoury, MJ and Flanders, WD (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!. Am J Epidemiol, 144:3, pp. 207-213.
44. Ohlsson, R. and Gondor, A. (2006) Epigenetics-cellular memories-affect disease development. Lakartidningen, 103:12, pp. 919-925.
45. Ballestar, E., Esteller, M. and Richardson, BC (2006) The epigenetic face of systemic lupus erythematosus. J Immunol, 176:12, pp. 7143-7147.
46. Januchowski, R., Prokop, J. and Jagodzinski, PP (2004) Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet, 45:2, pp. 237-248.